Published in Stat Med on June 15, 2002
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ (2005) 6.66
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making (2012) 3.36
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ (2016) 2.17
Rank reversal in indirect comparisons. Value Health (2012) 2.13
SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst (2009) 2.05
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Med Res Methodol (2002) 1.66
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart (2005) 1.61
The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol (2008) 1.46
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis. BMC Med Res Methodol (2016) 1.38
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med (2013) 1.35
Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One (2013) 1.34
A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol (2007) 1.30
Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology (2012) 1.26
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer (2011) 1.18
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev (2010) 1.15
Meta-Analysis of Rare Binary Adverse Event Data. J Am Stat Assoc (2012) 1.15
Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care (2008) 1.10
Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer (2011) 1.09
Children in reviews: methodological issues in child-relevant evidence syntheses. BMC Pediatr (2005) 1.01
Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods (2015) 1.01
Randomized trials, generalizability, and meta-analysis: graphical insights for binary outcomes. BMC Med Res Methodol (2003) 0.99
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review. BMC Infect Dis (2005) 0.98
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials. BMC Cancer (2010) 0.94
Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study. BMC Med Res Methodol (2011) 0.92
Role of systematic reviews and meta-analysis in evidence-based medicine. World J Surg (2005) 0.92
Transparent meta-analysis of prospective memory and aging. PLoS One (2008) 0.92
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis. Clin Res Cardiol (2015) 0.91
Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica (2010) 0.91
Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med (2003) 0.89
No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis. Ann Gen Psychiatry (2013) 0.89
Revisiting the relationship between baseline risk and risk under treatment. Emerg Themes Epidemiol (2009) 0.89
Drugs for pre-osteoporosis: prevention or disease mongering? BMJ (2008) 0.88
Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther (2014) 0.87
Assessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions? BMC Med Res Methodol (2005) 0.86
Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date. Dermatoendocrinol (2012) 0.84
Implementing GRADE: calculating the risk difference from the baseline risk and the relative risk. Evid Based Med (2013) 0.82
Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study. BMC Med Res Methodol (2014) 0.82
Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis. J Neurol (2014) 0.82
Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group. Syst Rev (2013) 0.81
The Many Flavors of Model-Based Meta-Analysis: Part I-Introduction and Landmark Data. CPT Pharmacometrics Syst Pharmacol (2016) 0.80
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev (2015) 0.79
Association between nutritional status and the immune response in HIV + patients under HAART: protocol for a systematic review. Syst Rev (2014) 0.79
Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs. Biom J (2015) 0.79
Stent-supported angioplasty versus endarterectomy for carotid artery stenosis: evidence from current randomized trials. Z Kardiol (2005) 0.78
Empirical evidence about inconsistency among studies in a pair-wise meta-analysis. Res Synth Methods (2015) 0.77
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings. Curr Neuropharmacol (2015) 0.75
Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis. Hum Vaccin Immunother (2016) 0.75
Student evaluations of teaching: teaching quantitative courses can be hazardous to one's career. PeerJ (2017) 0.75
Heart calcium sensitizer on morbidity and mortality of high-risk surgical patients with MODS: systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.75
Are some antidepressants better than others? Nat Rev Neurol (2009) 0.75
A sensitivity analysis framework for the treatment effect measure used in the meta-analysis of comparative binary data from randomised controlled trials. Stat Med (2012) 0.75
Efficacy of splint therapy for the management of temporomandibular disorders: a meta-analysis. Oncotarget (2016) 0.75
Commentary: On Effect Measures, Heterogeneity, and the Laws of Nature. Epidemiology (2015) 0.75
Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis. Clin Med Insights Blood Disord (2017) 0.75
Utility of near-infrared light devices for pediatric peripheral intravenous cannulation: a systematic review and meta-analysis. Eur J Pediatr (2016) 0.75
Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us. Am J Public Health (2017) 0.75
Erythropoietin for cancer-associated malignant anemia: A meta-analysis. Mol Clin Oncol (2017) 0.75